Particularly when it comes to distinguishing between astrocytomas and glioblastomas (GBMs), at the core of this differentiation lies a key piece of genetic code—the Isocitrate Dehydrogenase (IDH) gene [3,7]. This evidence concerns the gene IDH1 and glioblastoma.